Clinical trial · Observational
Tissue Sample Collection From Patients With Fanconi Anemia
Fanconi Anemia Cancer Cell Repository
NCT00899522CI-TRIAL-00030651completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
RATIONALE: Collecting and storing samples of tumor tissue from patients with Fanconi anemia to test in the laboratory may help the study of cancer in the future. PURPOSE: This laboratory study is collecting and storing tumor tissue samples from patients with Fanconi anemia.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Fanconi Anemia | — | UNRESOLVED | — |
| Unspecified Adult Solid Tumor, Protocol Specific | Adult Solid Neoplasm | ALIAS | 0.85 |
| Unspecified Childhood Solid Tumor, Protocol Specific | Childhood Solid Neoplasm | ALIAS | 0.85 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| biologic sample preservation procedure | Other | — | UNRESOLVED |
| biopsy | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (3)
- measure
- Creation of a Fanconi Anemia Cell Repository using rare solid tumor samples from patients with Fanconi anemia
- timeFrame
- Duration of the study
- measure
- Study tissue samples by molecular methods, including gene microarrays
- timeFrame
- Duration of the study
- measure
- Development of cancer cell lines from tissue archived from patients with Fanconi anemia
- timeFrame
- Duration of the study
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 1 Year
- Maximum age
- 55 Years
Show eligibility criteria text
DISEASE CHARACTERISTICS: * Confirmed Fanconi anemia * Confirmed malignant solid tumor * Biopsy of tumor tissue available PATIENT CHARACTERISTICS: * Not specified PRIOR CONCURRENT THERAPY: * Not specified
References
Publications (0)
Data not yet available
No reference posted for this study.